Saudi Arabia’s Avalon Pharma sets IPO price range

Saudi Arabia’s Avalon Pharma sets IPO price range

The company will offer six million shares, or 30 per cent of its issued share capital, on the Saudi Exchange

Avalon Pharma to sell 30% stake in Riyadh IPO

Saudi Arabia’s Avalon Pharma plans to list 30% on Tadawul

The pharmaceutical firm said the final offer price will be determined following a January 14-18 book-building period

Julphar posts Dhs859.4m in H1 revenues, up 2.5%

Julphar half-year revenues surge to Dhs859.4m on solid growth

The company registered double-digit growth in the UAE and GCC region markets due to continued positive developments in key markets including Saudi Arabia

Saudi pharmacy chain seeks $1.3bn in top IPO since Aramco

The firm received regulatory approval for the listing in December

Mubadala, G42 to set up biopharma manufacturing campus in Abu Dhabi

The facility will focus on vaccine and therapeutic products to “strengthen regional supply chains”

UAE cabinet

UAE cabinet approves conditions for housing loans exemptions for Emiratis

The cabinet during a meeting on Monday also approved a National Medicine Policy and a national strategy for cultural and creative industries

Abu Dhabi-based Yas Holding completes acquisition of Gulf Inject from Julphar

The acquisition comes as part of efforts to boost Yas Holding’s healthcare manufacturing and distribution ecosystem

‘The worst has passed’ – Sheikh Mohammed on the Covid-19 situation in the UAE

The Cabinet also approved the regulations governing medical and pharmaceutical products in the country

Jebel Ali Free Zone

Dubai’s Jafza healthcare, pharma customer base grows 12%

There are 174 companies within this sector in the free zone, employing 1,100 people

Saudi, Abu Dhabi wealth funds team up on Egyptian drugmaker deal

Public Investment Fund and ADQ are weighing the purchase of Bausch Health’s Cairo-based drug unit

Mubadala Kohlberg PCI

Abu Dhabi’s Mubadala and Kohlberg acquire majority stake in PCI Pharma Services

Philadelphia-based PCI provides a range of integrated pharmaceutical supply chain solutions

Ras Al Khaimah pharma company Julphar launches Dhs500m rights issue

The new capital is also expected to help it expand operations in key markets in the region

Lenders to Shetty’s pharma firm are said to start debt talks

Creditors will also consider plans to bring in a new strategic investor to Neopharma to keep the business operating

UAE pharma Julphar resumes exports to Saudi after suspension

The kingdom banned Julphar’s products in September 2018 for failing to meet regional standards